Grifols, a global healthcare company and leading manufacturer of plasma-derived medicines, has announced a collaboration with ...

Narrow-moat CSL reiterated fiscal 2025 guidance for constant-currency group net profit after tax before amortization, or NPATA, of USD 3.2 billion to­ USD 3.3 billion, implying 1 ...

Bitter melon leaves are not a proven treatment for rabies, experts told AFP, refuting "dangerous" online posts touting the ...

A milk allergy and lactose intolerance can cause similar symptoms after consuming dairy, but they are not the same. Here are ...

Two colostrum samples from the same farm may look identical, but the immunoglobulin concentration can vary significantly.

ADMA Biologics' growth potential with Asceniv makes it a compelling Buy. Click here to find out why ADMA stock is a Strong ...

BENGALURU: When the first outbreak happened in Pune, all heads turned and started to panic. What was this new infectious ...

Pharmaceuticals company CSL on Tuesday reported a 3% rise in first-half profit, benefiting from further growth in its main blood-plasma business.

Access to the live webcasts of these events, as well as archived recordings, will be available under the "Events” tab on the investor relations section of the SAB BIO website at ...

Spanish plasma-derived medicines specialist Grifols revealed it is collaborating with Dutch biotechnology start-up, FcR ...

Iran's National Institute of Genetic Engineering and Biotechnology (NIGEB) has developed an anti-cancer vaccine that will be ...